These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 13806439)
1. [Androstanolone-base in therapeutics]. BUSSIERE Rev Int Serv Sante Armees; 1959; 32():487-90. PubMed ID: 13806439 [No Abstract] [Full Text] [Related]
2. [Effects of androstanolone-base on 120 patients]. HUGUET FJ; TOURNIGAND P; DURAN G; PASTOR J Presse Med (1893); 1961 Dec; 69():2433-4. PubMed ID: 14449852 [No Abstract] [Full Text] [Related]
3. [Attempted correction with androstanolone of disorders of protein metabolism in cirrhotics]. TROCME P; ROY J Sem Hop Ther Paris; 1962 Jan; 38():22-5. PubMed ID: 13922546 [No Abstract] [Full Text] [Related]
4. [Virilizing action of a commerical preparation of androstanolone-base reputed to be without hormonal action]. PERROT R; TASSY ; CHAVANNES Arch Fr Pediatr; 1960; 17():246-8. PubMed ID: 14432008 [No Abstract] [Full Text] [Related]
5. [Androstanolone in massive doses as almost exclusive treatment of hepatic cirrhosis]. DUBARRY JJ; BIESSY R Rev Int Hepatol; 1959; 9():665-75. PubMed ID: 13818278 [No Abstract] [Full Text] [Related]
7. [Results obtained with the use of androstanolone and vitamin B 12 in childhood]. ANGELLOTTI OA Prensa Med Argent; 1959 Jun; 46():1618-25. PubMed ID: 13793684 [No Abstract] [Full Text] [Related]
8. [Principles and indications for therapy with protein-anabolic steroids]. KRUESKEMPER HL Internist (Berl); 1962 Jun; 3():323-32. PubMed ID: 14459903 [No Abstract] [Full Text] [Related]
9. [Trial of basic androstanolone in cancerous conditions of the ORL zone. Prevention of cicatrization disorders]. de THOMASSON ; LABAYLE J Gaz Med Fr; 1961 Mar; 68():723-5. PubMed ID: 13776547 [No Abstract] [Full Text] [Related]
10. The use of protein anabolizers. FOSS GL Br J Clin Pract; 1959 Aug; 13():541-5. PubMed ID: 13824088 [No Abstract] [Full Text] [Related]
11. [Clinico-experimental investigations of 1-methylandrostenolone with a protein-anabolic effect]. BREUER H; KRUESKEMPER HL; BARTSCH W Dtsch Med Wochenschr; 1962 Jun; 87():1349-53. PubMed ID: 13872948 [No Abstract] [Full Text] [Related]
12. [Influence of androstanolone on protein metabolism]. ANDREOLI M; CARRATU R Policlinico Prat; 1961 Jan; 68():73-9. PubMed ID: 14448344 [No Abstract] [Full Text] [Related]
13. Studies on the coal tar bases. V. Pyridine bases from low-temperature coking tar. IKEKAWA N Pharm Bull; 1953 Jun; 1(2):149-51. PubMed ID: 13155125 [No Abstract] [Full Text] [Related]
14. [Anabolic drugs and osseous consolidation. Apropos of the consolidation of fractures of the extremities in 145 cases treated with systematic addition of androstanolone-base to orthopedic or surgical treatment]. DOR V Vie Med; 1961; 42(2)():71-80. PubMed ID: 13723857 [No Abstract] [Full Text] [Related]
15. The use of androgens in men. HELLER CG; MADDOCK WO Bull N Y Acad Med; 1948 Mar; 24(3):179-94. PubMed ID: 18906635 [No Abstract] [Full Text] [Related]
16. [Protein deficiency states in surgery and their therapy]. JENKNER FL Med Welt; 1960 Apr; 16():838-40. PubMed ID: 13853127 [No Abstract] [Full Text] [Related]
17. Male hormone therapy. DUNN GW; HOFFMAN RH Clinics; 1946 Dec; 5(4):878-97. PubMed ID: 20283909 [No Abstract] [Full Text] [Related]